HomeBUSINESSDeal & Finance

Deal & Finance

Life Science M&A

Redazione - June 10, 2024

Deal & Finance

Roche takes aim at inflammatory bowel disease

Deal & Finance

Sanofi’s strategic turnaround

Deal & Finance

Goodbye NASH, it’s Alfasigma’s time

Deal & Finance

Agreement for antiviral biologics low cost production

Deal & Finance

Roche takes aim at inflammatory bowel disease

November 5, 2023

Deal & Finance

Sanofi’s strategic turnaround

October 29, 2023

Deal & Finance

Goodbye NASH, it’s Alfasigma’s time

October 17, 2023

Deal & Finance

Agreement for antiviral biologics low cost production

March 8, 2022

Deal & Finance

Baxter and Hillrom: advancing healthcare together

December 20, 2021

Deal & Finance

Highly potent API expansion for Olon Rodano site

August 6, 2021

Deal & Finance

IMA AUTOMATION incorporates all the companies of the Group dedicated to industrial automation

August 6, 2021

MakingPharmaIndustry
Contact us: info@makinglife.it

Making Pharmaindustry | The Magazine of the Pharma

October 1, 2024

Italy leads Europe in the fight against pharmaceutical crime

March 7, 2024

National Medicines Verification Systems

April 13, 2024

Il Responsabile per la Protezione dei dati avv. Monica Gobbato è raggiungibile a dpo@makinglife.it

Deal & Finance

Life Science M&A

Roche takes aim at inflammatory bowel disease

Sanofi’s strategic turnaround

Goodbye NASH, it’s Alfasigma’s time

Agreement for antiviral biologics low cost production

POPULAR POSTS

Making Pharmaindustry | The Magazine of the Pharma

Italy leads Europe in the fight against pharmaceutical crime

National Medicines Verification Systems

POPULAR CATEGORY